According to Inclusive Market Reports, Head and Neck Cancer Drugs Therapeutics Market size was valued at $ 1.45 Billion by 2019 and is anticipated to grow at a CAGR of 8.65% during the forecast period 2020-2025. The Head and Neck Cancer Drugs/Therapeutics Market growth rate is attributed to the development of innovative and cost-effective treatments, numerous side effects related to radiation therapy and chemotherapy, increased healthcare expenditure, and better government initiatives are poised to accelerate the growth of the market in the forecast period of 2020-2025. A variety of different malignant tumors that form in or around the throat, larynx, nose, sinuses, tongue, salivary glands, and mouth include head & neck cancers. For the treatment of head & neck cancer, there are various types of drugs used individually or in combination. Targeted immune therapies are emerging as a standard treatment choice for advanced-stage head & neck cancers, while conventional chemotherapeutic drugs are preferably used in combination with radiation therapy.